Paquinimod
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Paquinimod, covering 2014-08-27 to 2014-08-27. Get the full timeline:
Most recent: Clinical Trial Update: An Open-Label Study to Evaluate Biomarkers and Safety in Systemic Sclerosis Patients Treated With ABR-215757 (Paquinimod) [Phase 2]